Articles tagged with Hiv Research
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
The Scripps Research Institute team created a library of 50 synthetic compounds from natural Japanese-plant compounds, including one that shows great promise in inhibiting HIV replication and fighting inflammation. The compound has been identified as a promising lead for potential use as an HIV-fighting drug.
A new study by Stanford University School of Medicine researchers found that expanded HIV screening and treatment could prevent up to 212,000 new infections over the next 20 years. The strategy of one-time screening for low-risk individuals and annual screening for high-risk individuals is cost-effective.
Stephanie Willerth's research on HIV has significantly advanced understanding of the virus and its resistance to medications. Her study of over 15,000 different versions of the virus has led to the identification of specific genes resistant to drugs, paving the way for more effective treatments.
Global heterogeneity in HIV-1 strains affects properties like viral fitness and transmissibility. New forms will continue to emerge, necessitating updated prevention and control strategies.
Researchers found that certain mutations in the virus render it ineffective against drugs, but also impair its ability to kill immune cells. This discovery may lead to a new diagnostic tool and more effective treatments for HIV patients.
A clinical trial known as iPrEx found that taking antiretroviral drugs daily can significantly reduce the risk of HIV infection among men who have sex with men. The study involved 2,499 participants and showed a nearly 44% lower rate of HIV infections in those taking the drug.
A multinational trial found that taking an antiretroviral tablet daily can prevent HIV in gay men, with a 43.8% reduction in new infections compared to a placebo. Regular adherence and monitoring are crucial for this strategy to work.
The Global iPrEx study found that daily use of the oral antiretroviral combination pill was 44% effective in reducing risk of HIV infection in men who have sex with men. Risk of HIV infection fell by 50.2% among participants who took the pill at least 50% of the days.
The iPrEx trial found that once-daily TDF/FTC significantly reduced HIV risk among participants receiving a comprehensive prevention package, emphasizing the importance of adherence to the drug regimen. The results support PrEP as a promising prevention intervention for gay men and other men who have sex with men.
A strong link has been found between depression and risky sexual behaviors in South African youth, with depressed individuals more likely to engage in transactional sex and experience relationship violence. Researchers recommend routine screening for depression to reduce HIV risk in the region.
A new study finds that weekly SMS check-ins increase the likelihood of patients with HIV having undetectable viral loads, leading to better health outcomes and reduced transmission. The text-message support system showed a 12% increase in undetectable levels among participants.
Researchers will investigate the complex interactions between alcohol consumption and HIV, including brain and liver damage, adherence to antiretroviral medications, and safe sex practices. The goal is to determine whether individuals need to stop or reduce their drinking.
A consortium of researchers has designed an early phase safety trial to assess mosaic vaccines in humans. The trial aims to test the mosaic concept and potentially lead to the next generation of HIV vaccine candidates.
A new study found that single-dose nevirapine can hamper the drug's effectiveness if used later to treat HIV-infected women. The WHO has revised its guidelines to advise against using nevirapine in combination with other drugs, if treatment begins fewer than 12 months after exposure.
A new research method has provided unprecedented clarity on the behavior of the HIV protein Gag, which plays critical roles in the assembly of the human immunodeficiency virus. The study reveals new conformations of the protein and offers potential avenues for developing antiviral drugs.
A mobile outreach program staffed by current and former sex workers is associated with increased entry to detoxification and residential drug treatment among women in street-based sex work. The program provides a safe space for sex workers to rest and have access to health, support, and addiction treatment services.
A study published in Nature Medicine reveals a new strategy for protecting newborns against HIV by boosting their immune system. By educating part of the baby's immune system within the first few hours of birth, researchers hope to limit the levels of infection and extend lives.
Researchers at Rockefeller University have made two fundamental discoveries about broadly neutralizing anti-HIV antibodies, which effectively keep the virus at bay. They found that most antibodies bind to their target in a polyreactive manner, enhancing overall affinity by binding non-specifically to the virion.
A Phase I study has begun to evaluate a combination DNA prime/MVA vector boost vaccine regimen to protect against diverse subtypes of HIV-1. The study will enroll 92 participants and test two intramuscular delivery methods for the DNA prime, Biojector 2000 and CELLECTRA EP, to compare their effects on immune response.
Researchers will investigate biological mechanisms of broadly neutralizing antibody generation and its relevance to AIDS vaccine design. The U19 grant will support studies using samples from HIV-positive volunteers worldwide.
The NIH will fund a five-year research initiative to identify and treat HIV-positive inmates in the US prison system. The goal is to reduce HIV transmission and improve public health by linking those in incarceration to antiretroviral therapy and medical care.
A new study found that the effectiveness of anti-HIV drugs darunavir and ritonavir was similar between men and women. However, women dropped out of the trial at higher rates than men due to reasons other than drug failure. The study aims to improve retention of diverse populations in HIV treatment trials.
HIV-1 virus uses ATP to remove AZT, a widely used AIDS treatment, allowing it to replicate itself. This discovery helps researchers understand why anti-AIDS treatments can fail, enabling the development of more effective treatments for HIV patients.
A recent study by IRCM researchers revealed the crucial role of the Vpr protein in blocking cell division and triggering immune cell death during HIV infection. The findings suggest that targeting this process could lead to new potential therapeutic targets, providing a better understanding of HIV infection and AIDS.
Scientists have identified six critical amino acids in the TRIM5α protein that enable it to destroy HIV. Altering these amino acids in human cells renders TRIM5α ineffective against HIV-1 infection, highlighting a potential target for therapy development.
A cognitive-behavioral intervention to reduce substance use and sexual risk behavior among men who have sex with men was partially successful, but further research is needed to identify better methods. After one year, participants reported a 32% reduction in unprotected anal sex and similar reductions in other risk behaviors.
Researchers at the University of Minnesota have identified two FDA-approved drugs, decitabine and gemcitabine, which, when combined, may be an effective treatment for HIV. The drug combination forces the virus to mutate itself to death, a phenomenon dubbed 'lethal mutagenesis.'
Researchers found two mechanisms altering HIV-1 population in semen, including clonal amplification and compartmentalization. The study suggests the viral population in semen may be distinct from that in blood, affecting our understanding of transmission and selective pressures.
Researchers found HIV-1 virus alters in semen versus blood through two distinct mechanisms, affecting its replication and transmission.
A new research approach targets infected cells to eliminate HIV, offering a potential cure. By inducing programmed cell death, the approach aims to reduce the viral load and prevent disease progression. If successful, this therapy could lead to an eradication of the virus.
A work group led by a Kaiser Permanente researcher developed and adopted 17 national measures to assess HIV care quality, including screening, prevention, and antiretroviral therapy. These measures have been endorsed by several organizations and are being pilot-tested to improve patient outcomes.
A joint project of UCSF and KEMRI has received a 5-year grant to expand its care and support for people affected by HIV/AIDS in Kenya. The grant will allow the project to serve at least 80% of HIV patients needing care within its service areas.
A recent study by The Wistar Institute found that the newly identified human adenovirus AdHu26 commonly infects people, particularly those in Sub-Saharan Africa, rendering it an unlikely candidate as a vaccine carrier. In contrast, chimpanzee adenoviruses demonstrate similar functionality and are considered superior for mass vaccination.
Carol Iversen received the 2010 ICAAC Young Investigator Award for her research on Enterobacter sakazakii taxonomy. Her work led to the creation of a new genus Cronobacter, which has improved detection and isolation of the bacteria.
A new method of attack against the AIDS virus has been developed using a prevention system that stiffens cell membranes, making them impenetrable to the virus. This research, published in Chemistry & Biology, provides a novel focus on regulating cell membrane fluidity and preventing viral fusion.
A US-Mexico border program using a 35-minute behavioral intervention significantly reduced the incidence of HIV and STIs among female sex workers. The program, called Mujer Segura or Healthy Woman, was found to be cost-effective, with an estimated expense per intervention of less than $200.
Researchers gathered for a workshop to review and debate the latest research on HIV reservoirs, with the goal of controlling or eradicating the virus. Despite advances in antiretroviral therapy, HIV remains hidden in certain cells, making lifelong treatment necessary.
The Case Western Reserve University/University Hospitals Center for AIDS Research has received a five-year, $9 million NIH grant renewal to continue HIV-related research. The funding will support new initiatives on HIV and cancer links, faculty development, and international collaborations.
A new study finds that hazardous alcohol consumption is linked to increased HIV infection rates in Southern and Eastern Africa. Venue-based interventions have been shown to be effective in changing individual behavior and social norms, but more research is needed to address the gender gap in these programs.
A study of microbicide gel shows reduced risk of HIV and herpes infections in women, with a 39% effective reduction in HIV risk and 51% effective prevention against genital herpes. The gel contains 1% tenofovir and has the potential to prevent over half a million new HIV infections in South Africa alone.
A recent study found that using a vaginal microbicide with an antiretroviral drug called tenofovir significantly reduced HIV infections among women. The study involved 889 women from South Africa and found that those who used the gel before and after sex had 39% fewer HIV infections compared to those who used a placebo gel.
A vaginal gel containing 1% tenofovir has been shown to significantly reduce a woman's risk of HIV infection and genital herpes. The study found that the gel was 39% effective in reducing HIV risk during vaginal intercourse, increasing to 54% for women using the gel in over 80% of their sex acts.
Researchers found that only 51% of HIV-exposed infants received nevirapine, a minimal dose needed to protect them from mother-to-child transmission. The study highlights the need to expand programs and improve monitoring to address programmatic failures and common problems in preventing mother-to-child transmission.
A new study conducted jointly by researchers at the University of California, Berkeley, and other institutions found that people who received up to $60 each over 12 months for staying free of sexually transmitted infections (STIs) had a lower prevalence of those infections after a year compared to those who did not receive payments. Th...
The International AIDS Society (IAS) has announced the winners of four prestigious scientific awards, recognizing innovative HIV and AIDS research. The Women, Girls and HIV Investigator Prize was awarded to Naina Rani for her work on mainstreaming the Prevention of Parent to Child Transmission program in India.
The International AIDS Society has awarded $3.4 million in grants to 10 early-stage researchers from diverse scientific disciplines, aiming to advance HIV understanding and prevention approaches. The grantees will collaborate with CFAR institutions to explore pressing scientific questions on long-term survival and HIV transmission.
A new review of existing literature found that several factors influence willingness to receive an HIV vaccine, including misconceptions about vaccine efficacy and fear of side effects. To ensure a future HIV vaccine is acceptable, public education is crucial to address these concerns.
The report identifies key gaps in current knowledge and proposes a multi-disciplinary research approach to support HIV-positive women's reproductive health. The recommendations aim to enhance their ability to achieve their desired family size and promote healthy services.
A new study found that a culturally specific intervention program based on the African concept of Eban increased condom use and reduced acts of unprotected sex among heterosexual African American couples with differing HIV status. The program aimed to improve communication, relationship health, and community respect.
The International AIDS Society and National Institute on Drug Abuse have awarded fellowships to seven young researchers from around the world to study the intersection of drug use and HIV. The recipients will receive US$75,000 each to pursue groundbreaking research in biology, epidemiology, public health, behavioral sciences, and more.
The Fogarty International Center of the NIH has awarded a five-year, $3.6 million grant to an international AIDS training and research program to continue training foreign researchers in developing countries. The program supports established research training programs in India, Cambodia, the Philippines, and Kenya, and will also focus ...
Increasing HAART treatment for people with HIV/AIDS lowers viral load, stops HIV progression, and prevents transmission. A comprehensive economic analysis shows expanding HAART coverage in British Columbia can deliver a net benefit of $900 million over 30 years.
Research suggests that ostriches' wing-use and hindlimb function may help reconstruct locomotor techniques in bipedal dinosaurs. The study found that ostriches efficiently channel aerodynamic forces during rapid breaking, turning, and zigzag manoeuvres.
Researchers at NPL have confirmed a definitive structure of an HIV protein, shedding light on its infection mechanism. This discovery may lead to better treatments for people affected by HIV.
A longitudinal study found that women in relationships with low equality had a higher incidence of HIV compared to those with medium or high relationship power, highlighting the importance of addressing gender-based abuse and inequity in preventing HIV infection.
A randomized trial found that trained nurses can safely and effectively manage antiretroviral treatment, similar to doctor-monitored care. The study adds evidence to the success of 'task-shifting' in HIV care, which could help ease healthcare worker shortages and expand access to ART for millions in need.
A recent study has found that women who use IUDs are less likely to become pregnant compared to those using hormone injections. The IUDs' longer duration and lack of hormonal effects also make them a preferred long-term option.
Researchers found that mortality rates were significantly lower among patients who received DOT from a nominated treatment supporter compared to self-monitored ART. The study suggests that social capital and emotional support provided by these supporters contributed to improved survival outcomes.
The study found that 40-60% of Americans living with HIV/AIDS are smokers, twice the rate in the general population. Researchers emphasize the need for effective interventions to help these individuals quit smoking.
Researchers at Scripps Research Institute have determined the structure of an immune system antibody molecule that effectively acts against most strains of human immunodeficiency virus (HIV). The study advances the effort to develop an AIDS vaccine by providing insights into how broadly neutralizing antibodies work.